Hide Board Information

Show Board Information

Amphenol Corp. APH

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/02/2021 2:35:48 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 5

Amphenol Corporation (NYSE: APH)

Company Website: http://www.amphenol.com/

Amphenol Corp. (NYSE: APH) Stock Message Board

1. APH Company Profile

    

2. APH Time & Sales

    

3. APH Recent News

    

4. APH Filings

    

5. APH Financials

    

6. APH Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

2	Latest Amphenol Corp (APH) Headlines Ex-Dividend	Stock_Tracker	03/13/2014 8:25:32 PM
1	APH Stock Charts Last: -0.24 Monday, March 3,	chartguy89	03/03/2014 6:25:18 PM

Newer

Recent Articles

• Investors Seize Opportunity for Warner Bros. Discovery, Inc. Class Action
• Vertex Pharmaceuticals Delivers Promising CASGEVY Data Insights
• TECVAYLI® (teclistamab) Shows Efficacy for Newly Diagnosed Myeloma
• Promising Outcomes of Scemblix® in Combatting CML in Adults
• Roche's Polivy Breakthrough: A New Hope in Lymphoma Treatment
• Promising Phase 1 Data for Cemsidomide in Hematologic Cancers
• Agios Pharmaceuticals Reveals ENERGIZE-T Study Outcomes
• Significant Advances in Yescarta Outcomes for Lymphoma Patients
• bluebird bio Showcases Exciting Long-Term Results for Gene Therapy
• Genentech's Polivy Marks a Milestone in Lymphoma Treatment
• Apple Faces Class Action Over Alleged Failure to Prevent Child Abuse Material
• TECVAYLI® Shows Promise as a New Option for Multiple Myeloma
• Affimed's Combination Therapy Shows High Efficacy in Lymphoma
• Molecular Partners Showcases Innovative Cancer Treatments at ASH
• Cogent Biosciences Shows Promising Advances with Bezuclastinib
• ReAlta Life Sciences Shows Promise for RLS-0071 in aGVHD
• Investors Encouraged to Join Lilium N.V. Securities Class Action
• Rosen Law Firm Investigates Kaspi.kz for Investor Protection
• China's Economic Resilience: Growth Potential and Opportunities
• Revolutionary DARZALEX® Formulation Offers Hope for Myeloma Patients
• Investors Unite: Taking Action Against TD Bank Securities Losses
• Investigation of IMX Token Purchasers Announced by Law Firm
• Breakthrough Study Validates DARZALEX FASPRO for Myeloma Patients
• Epcoritamab Shows Promising Results in Chronic Lymphocytic Leukemia
• Current Water Technologies Inc. Faces Meeting Material Delays
• Epcoritamab Shows Promise for Relapsed Chronic Lymphocytic Leukemia
• CALQUENCE and Venetoclax Show Promise in CLL Treatment
• New Advances in Blood Cancer Treatments and Research Innovations
• Understanding Legal Actions for Wolfspeed, Inc. Investors
• Xiao-I Corporation Investors: Join the Class Action Now
• Austin Tice's Family Advocates for His Safe Return
• Recent Changes in Share Holdings of Max Stock Limited
• Exploring the Booming Downstream Processing Market Trends
• Projected Surge of Cyber Insurance Market to $97.3 Billion
• Liquid Handling Systems Market Growth: Trends and Insights Ahead
• Future of Lease Management Industry: Growth Insights and Trends
• Driving Forces Behind Overhead Cranes Market Growth Today
• Join the Fight: Class Action Lawsuit Against Match Group, Inc.
• Exploring Nanning: A City Where Cultures Meet and Flourish
• Growth and Trends of the IP Camera Market Through 2032
• mRNA Therapeutics Market Set for Massive Growth Towards 2032
• 3D Printing Materials Market Poised for Exponential Growth Ahead
• The Future of Medical Isotopes: Transforming Cancer Treatments
• Exclusive Holiday Gift Guide: Transformative Skincare for All
• Riyadh Action Agenda: A Global Push for Land Restoration
• Riyadh Philosophy Conference Concludes with Human-Centric Insights
• Prime Minister of Mongolia Strengthens Ties in Middle East
• Exploring the Timeless Artistry of Clay Figure Zhang Tradition
• University of Nebraska Triumphs in Abbott Blood Donation Challenge
• Exciting Phase 3 Trial Results for Poze-Cemdi in PNH Patients